The impact of transvenous lead extraction on tricuspid valve function

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 1, 2014, Pages 19-24

  Coffey, James O ^a   Sager, Solomon J ^a   Gangireddy, Sandeep ^b   Levine, Avi ^b   Viles Gonzalez, Juan F ^a   Fischer, Avi ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac implantable electronic device; device infection; device malfunction; lead extraction; tricuspid regurgitation; valvular heart disease

Indexed keywords

LEAD;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PROCEDURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MEDICAL DEVICE COMPLICATION; PACEMAKER; RETROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRANSVENOUS LEAD EXTRACTION; TRICUSPID VALVE; TRICUSPID VALVE FUNCTION; TRICUSPID VALVE REGURGITATION; VEIN OCCLUSION; VERY ELDERLY;

CARDIAC IMPLANTABLE ELECTRONIC DEVICE; DEVICE INFECTION; DEVICE MALFUNCTION; LEAD EXTRACTION; TRICUSPID REGURGITATION; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DEVICE REMOVAL; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY; VEINS; YOUNG ADULT;

EID: 84891837098     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12236     Document Type: Article

References (28)

1. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ,. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010; 33: 705-711.
2. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011; 58: 1001-1006.
3. Voigt A, Shalaby A, Saba S,. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol 2010; 33: 414-419.
4. Voigt A, Shalaby A, Saba S,. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48: 590-591.
5. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG Jr,. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004; 147: 582-586.
6. Kennergren C, Bjurman C, Wiklund R, Gabel J,. A single-centre experience of over one thousand lead extractions. Europace: European pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2009; 11: 612-617.
7. Jones SO, Eckart RE, Albert CM, Epstein LM,. Large, single-center, single-operator experience with transvenous lead extraction: Outcomes and changing indications. Heart Rhythm 2008; 5: 520-525.
8. Smith HJ, Fearnot NE, Byrd CL, Wilkoff BL, Love CJ, Sellers TD,. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol 1994; 17: 2016-2020.
9. Wilkoff BL,. How to treat and identify device infections. Heart Rhythm 2007; 4: 1467-1470.
10. Hauser RG, Hayes DL,. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 2009; 6: 605-610.
11. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007; 115: 2474-2480.
12. Field ME, Jones SO, Epstein LM,. How to select patients for lead extraction. Heart Rhythm 2007; 4: 978-985.
13. Gould PA, Krahn AD,. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. J Am Med Assoc 2006; 295: 1907-1911.
14. Birnie DH, Parkash R, Exner DV, Essebag V, Healey JS, Verma A, Coutu B, et al. Clinical predictors of fidelis lead failure: Report from the Canadian Heart Rhythm Society Device Committee. Circulation 2012; 125: 1217-1225.
15. Hussein AA, Wilkoff BL, Martin DO, Karim S, Kanj M, Callahan T, Baranowski B, et al. Initial experience with the Evolution mechanical dilator sheath for lead extraction: Safety and efficacy. Heart Rhythm 2010; 7: 870-873.
16. Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim SS, et al. Lead extraction in the contemporary setting: The LExICon study: An observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 2010; 55: 579-586.
17. Smith MC, Love CJ,. Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol 2008; 31: 736-752.
18. Bongiorni MG, Soldati E, De Lucia R, Marzilli M,. Techniques for transvenous leads extraction. Minerva cardioangiologica 2007; 55: 771-781.
19. Maytin M, Jones SO, Epstein LM,. Long-term mortality after transvenous lead extraction. Circ Arrhyth Electrophysiol 2012; 5: 252-257.
20. Hamid S, Arujuna A, Ginks M, McPhail M, Patel N, Bucknall C, Rinaldi C,. Pacemaker and defibrillator lead extraction: Predictors of mortality during follow-up. Pacing Clin Electrophysiol 2010; 33: 209-216.
21. Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR,. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: An observational study. J Am Soc Echocardiograph 2008; 21: 284-287.
22. Glover BM, Watkins S, Mariani JA, Yap S, Asta J, Cusimano RJ, Ralph-Edwards AC, et al. Prevalence of tricuspid regurgitation and pericardial effusions following pacemaker and defibrillator lead extraction. Int J Cardiol 2010; 145: 593-594.
23. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, Epstein LM, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085-1104.
24. Love CJ, Wilkoff BL, Byrd CL, Belott PH, Brinker JA, Fearnot NE, Friedman RA, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: Indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000; 23: 544-551.
25. Mehrotra D, Kejriwal NK,. Tricuspid valve repair for torrential tricuspid regurgitation after permanent pacemaker lead extraction. Texas Heart Institute journal/from the Texas Heart Institute of St Luke's Episcopal Hospital, Texas Children's Hospital 2011; 38: 305-307.
26. Assouan X, Thuny F, Deharo J, Franceschi F, Djiane P,. Heart Rhythm 2006. Severe tricuspid regurgitation after percutaneous ventricular lead extraction: Incidence and predisposing factors. Abstracts of the 27th Annual Meeting of the Heart Rhythm Society, Boston, Massachusetts, USA, May 17-20, 2006. Heart Rhythm 2006; 3: S12-S13.
27. Roeffel S, Bracke F, Meijer A, Van Gelder B, Van Dantzig JM, Botman CJ, Peels K,. Transesophageal echocardiographic evaluation of tricuspid valve regurgitation during pacemaker and implantable cardioverter defibrillator lead extraction. Pacing Clin Electrophysiol 2002; 25: 1583-1586.
28. Franceschi F, Thuny F, Giorgi R, Sanaa I, Peyrouse E, Assouan X, Prévôt S, et al. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol 2009; 53: 2168-2174.